Rwanda vs United States of America: Proportion of the target population who received a 3rd dose of
Rwanda
98.0%
in 2024
United States of America
84.0%
in 2024
Rwanda rank
7th
United States of America rank
6th
Proportion of the target population who received a 3rd dose of over time
- Rwanda
- United States of America
How they compare
Rwanda currently reports 98.0% against 84.0% in United States of America, a difference of 14.0%.
That makes Rwanda's figure about 1.2 times United States of America's.
Across all 15 years both countries report, Rwanda has been ahead every year.
Rwanda ranks 7th and United States of America ranks 6th of 157 countries.
Rwanda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Rwanda | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.7% | 92.6% | 5.1% | Rwanda |
| 2020s | 93.6% | 83.2% | 10.4% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Rwanda or United States of America?
- Rwanda, at 98.0% against 84.0% in United States of America as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Rwanda and United States of America?
- 14.0%, with Rwanda ahead.
- How many years of comparable data are there for Rwanda and United States of America?
- 15 years are reported by both, from 2010 to 2024.
- How do Rwanda and United States of America rank globally for proportion of the target population who received a 3rd dose of?
- Rwanda ranks 7th and United States of America ranks 6th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.